W ith a 5-year survival rate of less than 5%, pancreatic ductal adenocarcinoma (PDA) is among the most lethal of all human malignancies. 1, 2 The factors responsible for this frightening statistic include the resistance of pancreatic cancers to conventional chemotherapy and radiotherapy and the absence of early warning signs and symptoms. Despite a number of advances in basic and clinical pancreas biology, our understanding of the pathogenesis and the molecular mechanisms underlying PDA remain incomplete.
Three different ductal precursor lesions have been identified that give rise to invasive PDA: pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasia, and mucinous cystic neoplasia. [3] [4] [5] Of these, PanINs are the best characterized, being classified from low grade (PanIN-1) to high grade (PanIN-3) based on a number of histologic criteria including the degree of architectural and nuclear atypia. Activating mutations in the KRAS2 protooncogene are thought to be the initiating mutations responsible for PanIN-1 lesions. 4 Additional genetic modifications include telomere shortening, inactivation of the p16 INK4a locus (PanIN-2), and inactivation of the TP53, SMAD4/DPC4 genes (PanIN-3). 6 -9 Alterations in these oncogenes and tumor suppressor genes cause pleiotropic effects that lead to the deregulation of signaling pathways controlling cell proliferation, survival, adhesion, and migration. 2, 10 In an effort to model PDA, a number of mutant mouse strains have been developed that overexpress an activated Kras oncogene within specific pancreatic cellular compartments [11] [12] [13] [14] or that conditionally activate a mutant Kras allele from its own endogenous locus. [15] [16] [17] [18] In many instances, Kras G12D -expressing mice develop PanINs (referred to as mPanINs in mice) that on rare occasions progress to PDA after a long latency period (Ͼ1 year). Whereas PanINs can be modeled in mice, the identity of the initial target cell remains controversial. Although the histologic features of PanINs suggest a duct cell origin, several studies have proposed that acinar cells also may participate in PanIN development. 10,14,17,19 -21 The successful establishment of mouse models that mimic human disease has been a significant breakthrough in pancreatic oncology, although the role of individual transcription networks in PanIN development has not been fully studied. As a first step, we examined the importance of Mist1, a basic helix-loop-helix transcription factor that is expressed in pancreatic acinar cells but not in duct, islet, or centroacinar cells. 20, 22, 23 To investigate the importance of Mist1 and acinar cells to mPanIN initiation, we focused on the early events of mPanIN development in 3 different mutant Kras G12D model systems: Mist1 Kras/ϩ mice in which a Kras G12D coding region was targeted to the Mist1 locus, 13 LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice in which an endogenous Kras G12D allele was expressed upon "pan" pancreas Cre expression, 16 
Materials and Methods

Mouse Strains
Mist1 KrasG12D/ϩ (Mist1 Kras/ϩ ) mice 13 
Histology and Immunohistochemistry
Mouse pancreas tissues were processed as previously described. 20 
RNA Expression Analysis
Pancreas RNA was isolated using the RNeasy isolation system (QIAGEN, Valencia, CA) and reverse transcribed using the iScript complementary DNA (cDNA) synthesis kit (Bio-Rad, Hercules, CA). Polymerase chain reaction (PCR) conditions are described in Supplementary materials.
Acinar Cell Cultures
Primary acinar cells were isolated from wild-type or Mist1 LacZ/LacZ mice as described by Means et al. 28 After plating in 1.35 mg/mL collagen (BD Biosciences, San Jose, CA), the cells were supported with RPMI medium (Invitrogen, Carlsbad, CA) supplemented with 1% fetal bovine serum, 0.1 mg/mL soybean trypsin inhibitor, 1 g/mL dexamethasone, 100 U/mL penicillin, and 100 g/mL streptomycin. Transforming growth factor (TGF)-␣ (10 ng/mL or 50 ng/mL) (R&D systems, Minneapolis, MN) was added to the medium, and the efficiency of acinar-to-ductal conversion was measured after 5 days.
Results
Mist1 Is Essential for Survival of Mist1 Kras/؉ Mice
Previous studies showed that pancreata from Mist1 Kras/ϩ mice had significantly lower levels of the acinar-restricted transcription factor Mist1. 13 To establish whether loss of Mist1 protein was critical to the Mist1 Kras/ϩ phenotype, we generated Mist1 Kras/LacZ animals that expressed Kras G12D and ␤-gal from the Mist1 locus but lacked Mist1 protein. Although Mist1 Kras/LacZ mice appeared normal at birth, they rapidly lost body weight, became dehydrated, and died within 3 days ( Figure 1A ).
Newborn animals had a significantly enlarged pancreas that was ϳ10-fold larger than Mist1 LacZ/ϩ mice and ϳ2.5-fold larger than Mist1 Kras/ϩ mice ( Figure 1B ). As expected, control newborn Mist1 LacZ/ϩ animals exhibited normal acini and islet organization ( Figure 1C, a) . Mist1 Kras/ϩ pancreata also retained relatively normal exocrine organization with the exception that the lumina of the acini were often dilated, revealing early signs of acinar metaplasia ( Figure 1C , b). 13 In older animals (2-3 months), the presence of acinar/duct biphenotypic cells was readily observed as acinar cells transitioned to duct-like cells (Supplementary Figure S1) . 13, 20 In contrast to Mist1 Kras/ϩ mice, Mist1 Kras/LacZ pancreata were grossly distorted at birth, consisting of extensive epithelial tubular networks in which the normal apical-basal polarity of secretory granules, nuclei, and endoplasmic reticulum was lost, and individual cell boundaries were difficult to distinguish ( Figure 1C Figure 2C, b and c) . Mist1 Kras/LacZ /El pr -Mist1 myc mice survived for months, and acinar organization was largely restored, although areas of acinar metaplasia were similarly observed as in Mist1 Kras/ϩ animals. As predicted, the number of Ki67-positive cells also was significantly reduced (ϳ40%) in Mist1 Kras/LacZ /El pr -Mist1 myc mice. These results confirm that the absence of Mist1 promotes Kras G12D -induced cell proliferation and dramatically enhances pancreas transformation.
Loss of Mist1 Accelerates mPanIN Initiation in LSL-Kras G12D/؉ /ptf1a Cre/؉ Mice
Mist1 Kras/ϩ mice undergo acinar-ductal metaplasia and develop invasive and metastatic pancreatic cancer, 13 but, in the absence of Mist1 protein, the mice die shortly after birth, preventing a detailed analysis of early precursor lesions. To examine the importance of Mist1 to mPanIN initiation events, we turned to the Cre-activated LoxP-STOP-LoxP(LSL)-Kras G12D/ϩ model, which produces mPanINs when pancreas-restricted Cre expression is provided by pdx1 pr -Cre or ptf1a Cre/ϩ mouse lines. 16, 20 Mist1 LacZ/LacZ / LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice were generated by crossing LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice to Mist1 LacZ/LacZ mice. At 6 weeks of age, control LSL-Kras G12D/ϩ /ptf1a ϩ/ϩ mice (lacking Cre) exhibited average-sized pancreata with normal histologic features ( Figure 3A) . As previously reported, 16 Mist1 ϩ/ϩ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice developed slightly enlarged pancreata that otherwise had normal gross structure. In contrast, Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ pancreata were significantly larger than pancreata from con- trol littermates, paralleling the increased size phenotype of Mist1 Kras/LacZ mice ( Figure 3A) .
We next compared mPanIN initiation and progression between LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice maintained on a Mist1 ϩ/ϩ or Mist1 LacZ/LacZ genetic background. Animals of both genotypes showed rare mPanIN-1A lesions surrounded by normal acinar structures at 3 weeks of age (data not shown). However, mPanIN lesions developed much more rapidly in Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice where mPanIN-1A lesions were commonly seen at 4 weeks, and, by 6 weeks, mPanIN-1A distribution was extensive throughout the entire pancreas ( Figure 3B  and C, b) . Contrary to these results, mPanIN formation in 6-week Mist1 ϩ/ϩ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ animals remained rare and focally localized ( Figure 3C, a) . Significantly, high-grade mPanIN-2 and mPanIN-3 lesions were also much more abundant in Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ / ptf1a Cre/ϩ mice ( Figure 3B and C, c-e 
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levels of mucin, expression of the duct-restricted marker K19, and activation of Notch downstream signaling targets such as Hes1 ( Figure 3C, f-h ). Cells within Mist1 LacZ/LacZ / LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mPanINs were also highly proliferative ( Figure 3C, i) . Interestingly, real-time reversetranscription (RT)-PCR revealed a dramatic change from acinar gene products (amylase) to duct gene products (K19) in 6-week Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ pancreata (Supplementary Figure S3) suggesting a switch from predominantly acinar to predominantly ductal cell types in young mice expressing Kras G12D but lacking Mist1. Whether this reflects a conversion of acinar cells to ductal cells is not known, but acinar cells clearly contribute to mPanIN formation in this model since ␤-galpositive cells (expressed from the Mist1 locus) were readily observed in mPanINs of Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ / ptf1a Cre/ϩ pancreata ( Figure 3C, j-l) . 20 
LSL-Kras G12D/؉ /Mist1 Cre-ER/Cre-ER Mice Reveal That Mist1 Null Acinar Cells Readily Generate Advanced mPanINs Upon Kras G12D Expression
The presence of ␤-galϩ cells in mPanINs from Mist1 LacZ/ϩ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ and Mist1 LacZ/LacZ /LSLKras G12D/ϩ /ptf1a Cre/ϩ mice suggested that Kras G12D expressing acinar cells are the major cellular source of mPanINs in this model. To examine this in greater detail, we generated Mist1 Cre-ER/ϩ mice in which the complete Mist1 coding region was replaced with a Cre-ER T2 coding region. Using the R26R reporter line, tamoxifen-induced Cre activity was observed primarily in Mist1 Cre-ER/ϩ acinar cells, although a small percentage (Ͻ3%) of islet cells also exhibited ␤-gal activity ( Figure 4A, a and b) . Importantly, all cells from small and large ducts remained ␤-gal negative, confirming that the Mist1 locus is not expressed in this pancreas compartment. Administering tamoxifen to 6-week LSL-Kras G12D/ϩ /Mist1 Cre-ER/ϩ mice led to mPanIN-1A formation that mimicked the pattern observed with LSLKras G12D/ϩ /ptf1a Cre/ϩ mice ( Figure 4B, a-c) . Similarly, tamoxifen induction in adult LSL-Kras G12D/ϩ /Mist1 Cre-ER/Cre-ER mice (lacking Mist1) also readily generated mPanINs, but, in this instance, the number and grade of mPanINs were greatly accelerated, paralleling the results obtained with Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice. mPanIN-2 and mPanIN-3 lesions with atypical nuclei and large papillary extensions were often observed fusing to normal ductal epithelial ( Figure 4B, d-f; 4C) . As predicted, the mPanINs from LSL-Kras G12D/ϩ /Mist1 Cre-ER/Cre-ER mice exhibited duct cell characteristics, including expression of K19 ( Figure 4B, g ). R26R lineage tracing of LSL-Kras G12D/ϩ / Mist1 Cre-ER/Cre-ER mice confirmed the acinar cell origin of the advanced mPanINs in which virtually all expressed ␤-gal, whereas duct cells remained ␤-gal negative ( Figure  4B, h) . Based on these results, we conclude that the absence of Mist1 promotes Kras G12D -expressing acinar cells to form ductal mPanINs.
EGFR Signaling Is Hyperactive in Kras G12D
Expressing Cells Lacking Mist1
Several studies have shown that EGFR signaling can induce acinar cells to transition to duct-like cells in a number of pancreatic cancer mouse models. 20, 21, 29, 30 The increased propensity by which loss of Mist1 and Kras signaling generates mPanIN lesions also suggests that Mist1 LacZ/LacZ cells are primed to influence mPanIN formation, possibly through activation of EGFR downstream signaling pathways. To evaluate whether EGFR-signaling components are differentially active in Mist1 LacZ/LacZ and LSL-Kras G12D/ϩ /ptf1a Cre/ϩ animals, 6-week pancreata from different mouse genotypes were isolated and processed for real-time RT-PCR, immunoblot, and immunohistochemistry analyses. As shown in Figure 5A , transcript levels for the EGFR family members ErbB1 and ErbB2, as well as the target ligands TGF-␣ and HB-EGF, were not significantly different between control Mist1 ϩ/ϩ /LSL-Kras G12D/ϩ (WT) and Mist1 ϩ/ϩ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ (WT ϩ Kras) animals. In contrast, moderate (2-to 3-fold) increases in ErbB1 and TGF-␣ transcript levels were always observed in Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ (KO) animals ( Figure 5A ). However, when the Mist1 LacZ/LacZ genotype was combined with active Kras G12D (KO ϩ Kras), large (30-to 500-fold) increases in ErbB1, ErbB2, TGF-␣, and HB-EGF transcripts were produced ( Figure 5A ).
Immunoblot analyses on additional animals confirmed that the levels of ErbB1 were increased in the Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ pancreata ( Figure 5B ). As predicted, components of the MAPK pathway were also activated, including elevated levels of phospho-MEK1/2 and phospho-Erk1/2 ( Figure 5B ). Interestingly, these pathways were similarly active in control Mist1 LacZ/LacZ / LSL-Kras G12D/ϩ samples lacking Mist1 and Kras G12D protein (KO). Stat3, another downstream effector of the ErbB pathway, 31 was also activated in the Mist1 LacZ/LacZ samples. Indeed, immunohistochemistry confirmed that the increase in pStat3 levels was exclusively due to expression in acinar cells ( Figure 5C ). These results reveal that loss of Mist1 triggers MAPK and Stat3 signaling in acinar cells and suggest that the extreme phenotype associated with Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ and LSL-Kras G12D/ϩ /Mist1 Cre-ER/Cre-ER animals is due to a convergence of signaling components involving Kras G12D expression and hyperactivity of the EGFR pathway in the absence of Mist1.
Mist1 LacZ/LacZ Acinar Cells Rapidly Convert to Duct-Like Cells in 3D Cultures
The large increase in mPanINs in very young Mist1 LacZ/LacZ /LSL-Kras G12D/ϩ /ptf1a Cre/ϩ and LSL-Kras G12D/ϩ / Mist1 Cre-ER/Cre-ER animals suggested that Mist1 KO pancreata are highly sensitive to Kras G12D signaling events and that the response to Kras G12D expression may induce acinar cells to develop duct-like properties, including expression of K19, formation of tubular complexes, and participa-tion in mPanIN formation. Indeed, Mist1 LacZ/LacZ pancreata exhibit hyperactive EGFR signaling, suggesting that this pathway may accelerate conversion of acinar cells to mPanINs. To determine whether Mist1 LacZ/LacZ acinar cells were "primed" to attain duct cell properties, we turned to a 3-dimensional (3D) in vitro culture system to evaluate how acinar cells from Mist1 ϩ/ϩ and Mist1 LacZ/LacZ animals responded to EGFR-signaling pathways. As previously reported, 28 acinar cells from control Mist1 ϩ/ϩ mice placed in 3D collagen gels remained as acinar cells over a 5-day period ( Figure 6A, a-d; 6B and C) . However, when the cultures were supplemented with 10 ng/mL TGF-␣, a small percentage (ϳ20%) of cells acquired duct-like properties, forming ductal cysts and expressing the duct cell product K19 ( Figure 6A , e-h; 6B). Increasing TGF-␣ to 50 ng/mL led to a maximum 45% cell conversion. In contrast, Mist1 LacZ/LacZ cells were much more efficient in ductal conversion. The majority (Ͼ90%) of Mist1 LacZ/LacZ acinar cells readily formed ductal cysts when placed in collagen gels containing as low as 10 ng/mL TGF-␣ ( Figure 6B and  C) . Indeed, even in the absence of TGF-␣, small (ϳ5%) but reproducible numbers of Mist1 LacZ/LacZ acinar cells spontaneously converted to ductal cysts ( Figure 6B) . Thus, the absence of Mist1 primes cells for ductal conversion, mimicking the accelerated mPanIN formation in Mist1 LacZ/LacZ / LSL-Kras G12D/ϩ /ptf1a Cre/ϩ and LSL-Kras G12D/ϩ /Mist1 Cre-ER/Cre-ER mice.
Discussion
Identifying the earliest events that initiate PanIN formation is critical to understanding fully the origins of pancreatic cancer. Defining PanIN development has been difficult from a clinical perspective because patients often present with advanced disease. Thus, despite some progress in disease management, there remains uncertainty about which cell types contribute to PanIN development and which intracellular pathways are critical to PanIN progression.
To examine whether alterations to the acinar cell transcriptional network could affect Kras G12D -induced early events, we evaluated the importance of Mist1, an acinar-restricted bHLH transcription factor, to mPanIN formation. Our studies demonstrated that mice lacking Mist1 were highly sensitive to Kras G12D expression, exhibited early acinar-ductal metaplasia (Mist1 Kras/ϩ model), and showed greatly accelerated mPanIN initiation and progression (LSL-Kras G12D/ϩ model). Because Mist1 is not expressed in duct cells, these results reveal that altering the acinar Mist1 transcriptional network has a profound effect on the development of mPanIN lesions.
At this time, it is unclear why loss of Mist1 generates Kras G12D sensitivity. Mist1 LacZ/LacZ pancreata exhibit alterations in acinar cell organization where cells acquire defects in apical-basal polarity, 25 intercellular communication, 32 and regulated exocytosis. 33 Mist1 LacZ/LacZ mice also are susceptible to cerulein-induced pancreatitis, 34 suggesting that dysplasia of Mist1 LacZ/LacZ acinar cells may provide a sufficient epigenetic environment in which Kras G12D expression efficiently initiates mPanIN development. Indeed, patients with chronic pancreatitis are more susceptible to developing PDA, 35 and studies from Guerra et al 17 have confirmed that PanIN formation is greatly enhanced in mice with chronic pancreatitis. Nonetheless, loss of Mist1 is an intrinsic event restricted to acinar cells-centroacinar cells and duct cells do not express Mist1. 20 Thus, either dysplastic acinar cells influence the local environment to allow duct cells to develop into proliferative mPanINs or acinar cells directly participate in mPanIN formation. Although both scenarios are possible, we favor the latter for a number of reasons. First, Mist1 Kras/ϩ mice express Kras G12D exclusively from the Mist1 locus and yet develop rare mPanIN lesions and several different pancreatic tumor types with ductal features. 13 Second, LSL-Kras G12D/ϩ /ptf1a Cre/ϩ mice develop acinar metaplastic units that contain biphenotypic cells, suggesting that acinar cells contribute to mPanINs in The transcriptional network through which Mist1 operates has yet to be defined, although several Mist1 target genes have been identified, including the gap junction gene connexin32 32 and the cyclin-dependent kinase inhibitor gene p21 CIP1/WAF1 . 36 Loss of both proteins is known to lead to cellular hyperplasia, and it is possible that, upon Kras G12D expression, the absence of these key regulators in Mist1 LacZ/LacZ mice accelerates acinar cells to acquire a duct-like phenotype toward mPanIN formation. The possibility also exists that loss of Mist1 during Kras activation is not simply a consequence of acinar metaplasia but rather is a defined molecular pathway that is intimately associated with Kras G12D -induced pancreas transformation. Indeed, preliminary data support a model in which the human Mist1 locus is silenced as acinar cells undergo acinar-ductal metaplasia and PanIN formation in diseased tissues (Supplementary Figure S4) . 20 Despite a deficiency in understanding the transcriptional networks involved in tumor promotion, the signaling pathways through which activated Kras induces PDA have been well characterized, with many studies showing that the Notch and EGFR pathways are instrumental in complementing Kras signaling. 21, 37 The EGFR pathway also has been implicated in acinar-ductal metaplasia, 19,28 -30 suggesting that events controlling conversion of acinar cells to duct-like mPanINs share overlapping regulatory pathways with tumor promotion. In this current study, we showed that Mist1 LacZ/LacZ acinar cells precociously activate the EGFR-signaling pathway and are primed to convert to ductal cysts in vitro. Preliminary studies also have revealed that the Notch-signaling pathway is active in Mist1 LacZ/LacZ pancreata where Hes1 expressing acinar cells are readily identified (Supplementary Figure S5 ). This is a significant finding because induction of Notch signaling is thought to be an early event in PanIN initiation and pancreatic tumorigenesis. 21, 38 Despite precocious activation of the EGFR (pMEK1/2, pErk1/2, pStat3)-and Notch (Hes1)-signaling pathways in Mist1 LacZ/LacZ acinar cells, activation of these pathways alone is not sufficient to generate PanIN lesions. Kras G12D activity is still required. Nonetheless, acinar cells deficient in Mist1 are highly susceptible to Kras G12D -induced events and show a greatly increased, accelerated rate of mPanIN formation. These results suggest that the EGFR and Notch pathways likely cooperate with a distinct Kras G12D downstream pathway (eg, PI3 kinase, RalGDS, p120-GAP) to increase the efficiency by which individual acinar cells generate PanIN lesions. Whether identical pathways converge in the human disease will have to await a more thorough analysis of PanIN progression in patients. Continued studies of the molecular pathways and transcriptional networks that operate in both normal and neoplastic pancreatic cells will be critical to 
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delineating the individual components that lead to the generation of this deadly disease.
